Syschem (India) Ltd

Syschem (India) Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 14 May 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 26 May 2026, providing investors with the latest insights into its performance and outlook.

Syschem (India) Limited, a micro-cap pharmaceutical company engaged in manufacturing active pharmaceutical ingredients (APIs) and intermediates, reported a dramatic revenue surge in Q4 FY26, though profit volatility and an unusually high tax rate raised questions about earnings quality. The stock, trading at ₹50.12 with a market capitalisation of ₹245.65 crores, has delivered a modest 12.25% return over the past year, underperforming its pharmaceutical sector peers whilst navigating significant operational challenges.

Syschem (India) Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its valuation parameters, prompting a downgrade in its mojo grade from Buy to Hold. This change reflects evolving market perceptions amid rising price-to-earnings and price-to-book ratios, signalling a transition from fair to expensive territory for investors.

Syschem (India) Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive rating. This change reflects a recalibration of price-to-earnings and price-to-book value metrics relative to historical averages and peer benchmarks, signalling a potentially opportune moment for investors to reassess the stock’s price attractiveness amid mixed market returns.

Syschem (India) Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 14 May 2026. This revision reflects a reassessment across four critical parameters: quality, valuation, financial trend, and technicals. Despite impressive recent earnings growth and promoter confidence, the stock’s valuation and management efficiency have prompted a more cautious stance.

Syschem (India) Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen a notable shift in its valuation parameters, moving from a fair to an expensive rating. This change reflects evolving market perceptions and has implications for investors assessing the stock’s price attractiveness amid its recent performance and sector dynamics.

Syschem (India) Ltd has been upgraded from a Hold to a Buy rating following a comprehensive reassessment of its technical indicators, valuation metrics, financial trends, and overall quality. The micro-cap pharmaceutical and biotechnology company has demonstrated robust market performance and operational improvements, prompting a positive revision in its investment grade to a Mojo Score of 72.0.

Syschem (India) Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its valuation parameters shift favourably, moving from fair to attractive territory. This change comes amid a backdrop of mixed sector performance and evolving market dynamics, prompting a reassessment of the stock’s price attractiveness relative to its peers and historical benchmarks.

Syschem (India) Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 20 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 May 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Syschem (India) Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen a notable shift in its valuation parameters, moving from a fair to an attractive rating. This change reflects evolving market perceptions amid mixed financial metrics and peer comparisons, offering investors a fresh perspective on the stock’s price attractiveness.

Syschem (India) Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 20 Apr 2026. This revision reflects a combination of shifting technical indicators, a recalibrated valuation profile, and evolving financial trends, signalling a more cautious stance for investors despite the company’s strong long-term performance.

Syschem (India) Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Hold to Buy as of 15 April 2026. This change reflects significant improvements across technical indicators, valuation metrics, financial trends, and overall quality assessments, signalling renewed investor confidence in the company’s prospects.

Syschem (India) Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 03 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.